Seung‐Tae Lee

Also affiliated with Nexen (Canada), University Health System, Yonsei University Health System

Social SciencesEngineeringMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma”.

Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma

New England Journal of Medicine(2024)10.1056/nejmoa2401532

N/A

1.5DataRank · unranked

68 citations

Rahul Lakhotia, Stefania Pittaluga, James D. Phelan, Da Wei Huang, George W. Wright +31 more

Establishment of a novel human iPSC line (YCMi003-A) from a patient with dilated cardiomyopathy carrying genetic variant LMNA p.Asp364His

Stem Cell Research(2021)10.1016/j.scr.2021.102508

N/A

0DataRank · unranked

2 citations

Sun‐Ho Lee, Sun-Ho Lee, Jungyoon Choi, Jong Rak Choi, Sangwoo Kim +9 more

Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study

Frontiers in Oncology(2022)10.3389/fonc.2022.858202

N/A

0DataRank · unranked

19 citations

Elizabeth M. Corley, Hanan Alharthy, Kathryn Kline, Jennie Y. Law, Seung‐Tae Lee +5 more

Combinatorial Efficacy and Toxicity of an Engineered Toxin Body MT-3724 with Gemcitabine and Oxaliplatin in Relapsed or Refractory Diffuse Large B Cell Lymphoma

Cancer Investigation(2023)10.1080/07357907.2022.2162073

N/A

0DataRank · unranked

1 citations

Ahmed M. Galal, David A. Rizzieri, Sant P. Chawla, Seung‐Tae Lee, Angela Georgy +4 more

Trial in Progress: A Phase 1b Study of AS-1763, an Oral, Potent and Selective Noncovalent BTK Inhibitor, in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Blood(2023)10.1182/blood-2023-182568

N/A

0DataRank · unranked

1 citations

James D’Olimpio, Andew gillis-Smith, Seung‐Tae Lee, Nirav N. Shah, Javier Pinilla‐Ibarz +9 more